9303226C-203F-4A00-A4B0-6FD2AE26561FImmune-checkpoint therapy in non-small cell lung carcinoma:molecular characterisation of tumour microenvironment to improve anti-PD1/PD-L1 drug class.FellowshipMR/R016909/1C008C651-F5B0-4859-A334-5F574AB6B57CMRCINCOME_ACTUAL240333A4A3ED28-8A12-499A-B55D-8D0656655821PD-L1 expression in non-small cell lung cancer according to specimen type; a retrospective study of over 2,000 casesLung Cancer82d714bbda1e52948a34f4d21667f89eElwin F2020-01-01http://dx.doi.org/10.1016/s0169-5002(20)30159-8http://dx.doi.org/10.1016/s0169-5002(20)30159-8Journal Article/Review5e38270a0c34c2.73238908